Literature DB >> 9304433

Ocular activity of topically administered anandamide in the rabbit.

Y Mikawa1, S Matsuda, T Kanagawa, T Tajika, N Ueda, Y Mimura.   

Abstract

Marijuana and its psychoactive constituents, cannabinoids, reduce intraocular pressure (IOP) in humans and animals. Because anandamide, a recently discovered endogenous ligand of cannabinoid receptors, reportedly shows cannabimimetic pharmacological activity, we examined its effect on the eye. Varying amounts of anandamide, in 50 microL of light mineral oil, were topically applied to a rabbit eye and changes in IOP and ocular symptoms were monitored. Anandamide (50 micrograms to 1 mg) induced a significant decrease in IOP within 1 hour after administration; maximum reduction occurred at 2 hours; and there was a return to baseline by 7 hours following administration. A noticeable hyperemia of conjunctival blood vessels was also noted 2 hours after administration. Neither mineral oil alone or with palmitylethanolamide (an analogue of anandamide) caused a significant decrease in IOP or conjunctival hyperemia. This study indicates that anandamide does produce cannabimimetic effect in rabbit eyes.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9304433     DOI: 10.1016/s0021-5155(97)00050-6

Source DB:  PubMed          Journal:  Jpn J Ophthalmol        ISSN: 0021-5155            Impact factor:   2.447


  6 in total

1.  The In Vivo Effects of the CB1-Positive Allosteric Modulator GAT229 on Intraocular Pressure in Ocular Normotensive and Hypertensive Mice.

Authors:  Elizabeth A Cairns; Anna-Maria Szczesniak; Alex J Straiker; Pushkar M Kulkarni; Roger G Pertwee; Ganesh A Thakur; William H Baldridge; Melanie E M Kelly
Journal:  J Ocul Pharmacol Ther       Date:  2017-07-18       Impact factor: 2.671

2.  Effects of topical anandamide-transport inhibitors, AM404 and olvanil, on intraocular pressure in normotensive rabbits.

Authors:  K Laine; T Järvinen; J Savinainen; J T Laitinen; D W Pate; K Järvinen
Journal:  Pharm Res       Date:  2001-04       Impact factor: 4.200

3.  Effects of palmitoylethanolamide on aqueous humor outflow.

Authors:  Akhilesh Kumar; Zhuanhong Qiao; Pritesh Kumar; Zhao-Hui Song
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-07-03       Impact factor: 4.799

4.  Evidence for a GPR18 Role in Diurnal Regulation of Intraocular Pressure.

Authors:  Sally Miller; Emma Leishman; Olivia Oehler; Laura Daily; Natalia Murataeva; Jim Wager-Miller; Heather Bradshaw; Alex Straiker
Journal:  Invest Ophthalmol Vis Sci       Date:  2016-11-01       Impact factor: 4.799

Review 5.  Palmitoylethanolamide, a Natural Retinoprotectant: Its Putative Relevance for the Treatment of Glaucoma and Diabetic Retinopathy.

Authors:  Jan M Keppel Hesselink; Ciro Costagliola; Josiane Fakhry; David J Kopsky
Journal:  J Ophthalmol       Date:  2015-11-18       Impact factor: 1.909

6.  Harnessing the Endocannabinoid 2-Arachidonoylglycerol to Lower Intraocular Pressure in a Murine Model.

Authors:  Sally Miller; Emma Leishman; Sherry Shujung Hu; Alhasan Elghouche; Laura Daily; Natalia Murataeva; Heather Bradshaw; Alex Straiker
Journal:  Invest Ophthalmol Vis Sci       Date:  2016-06-01       Impact factor: 4.799

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.